Quarter Financials
Hyloris Pharmaceuticals SA (HYL.BR)
13.9 €
-0.08 (-0.57%)
Retained Earning Schedule
| Year | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q2 | 2020 Q1 |
|---|---|---|---|---|---|
| Net Income | - | - | - | -2 | -2 |
| Dividend Paid | - | - | - | - | - |
| Retained Earnings | -60 | -55 | -51 | -40 | -38 |
PPE Schedule
| Year | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q2 | 2020 Q1 |
|---|---|---|---|---|---|
| Capital Expenditure | - | - | - | -0 | -0 |
| Net PPE | 0 | 0 | 0 | 0 | 0 |
Intangible and Goodwill Schedule
| Year | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q2 | 2020 Q1 |
|---|---|---|---|---|---|
| New Purchases | - | - | - | - | - |
| Intangible and Goodwill | - | - | - | - | - |